Luciferase Reporter Cell Line - BIU-87

The BIU-87 cell line is a well-established human bladder cancer cell line derived from a primary bladder tumor. Originating from a male bladder cancer patient, this cell line exhibits epithelial cell morphology and is frequently used in oncology research due to its robust growth characteristics and close resemblance to human bladder cancer pathology. BIU-87 cells are commonly used to study tumor biology, drug resistance mechanisms, and metastasis. These cells retain key characteristics of bladder cancer, including the expression of specific biomarkers and responsiveness to chemotherapeutic agents, making them a valuable model for preclinical research. Researchers utilize BIU-87 cells to explore cellular pathways involved in bladder cancer progression, such as apoptosis, angiogenesis, and signal transduction, gaining insights that may contribute to the development of novel therapeutic strategies.

The luciferase reporter gene cell line – BIU-87 is a genetically engineered derivative of the parental BIU-87 cells, stably transfected with the luciferase gene. This modification allows for real-time, non-invasive monitoring of cellular processes through bioluminescence imaging. In drug discovery, this cell line is a powerful tool for high-throughput screening of anti-cancer compounds, as changes in luminescence intensity directly correlate with cell viability, proliferation, or specific pathway activation. Researchers can also implant these cells into animal models to track metastasis or treatment efficacy via bioluminescent signals, thus studying tumor growth dynamics in vivo. Furthermore, this reporter system facilitates the study of gene expression regulation, promoter activity, and signaling pathways by coupling luciferase expression to responsive elements. This cell line significantly enhances the precision and efficiency of oncology experiments, accelerating the development of targeted therapies for bladder cancer.